Healthcare -
Biotechnology - NASDAQ - US
$ 5.27
2.53 %
$ 112 M
Market Cap
-0.96
P/E
ENTA - TOTAL OTHER INCOME
Total Other Income ENTA - Enanta Pharmaceuticals, Inc.
3.9 M
LAST VALUE
53.52%
2 YEAR CAGR
-15.04%
5 YEAR CAGR
30.01%
10 YEAR CAGR